- জেনেরিক নাম
- Trimetazidine Dihydrochloride
- শক্তি
- 35 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Orion Pharma Ltd.
৳ ৫.৮৮ ৳ ৬.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
বাংলাদেশে Angimet MR 35 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Trimetazidine Dihydrochloride আছে (৩৫ mg)। তালিকাভুক্ত প্রতি ইউনিটের দাম ৬ টাকা। Angimet MR-এর সাথে Trimetazidine Dihydrochloride-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। Angimet MR প্রস্তুত করেছে Orion Pharma Ltd। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Trimetazidine Dihydrochloride-এর ১৩টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ৩টি। সবচেয়ে কম দাম Feelnor 20 mg Tablet-এর, প্রতি ইউনিট ৳ ৩।
Angimet MR is a 35 mg tablet made by Orion Pharma Ltd. Its active ingredient is Trimetazidine Dihydrochloride, which belongs to a group of other anti-anginal and anti-ischaemic drugs. It works by shifting the heart's energy production toward glucose, which uses oxygen more efficiently. Angimet MR is prescribed to adults as add-on therapy for the symptomatic treatment of stable angina pectoris when first-line antianginal medicines do not control symptoms well enough or are not tolerated. The doctor decides the dose and course.
Angimet MR is used in adults as add-on therapy for the symptomatic treatment of stable angina pectoris. It is for people whose symptoms are not adequately controlled by first-line antianginal therapies or who cannot tolerate them. It is not a curative treatment for angina attacks, not an initial treatment for unstable angina, and not a treatment for myocardial infarction. Ask the doctor if you are unsure whether it is suitable for you.
Angimet MR is a tablet to be taken by mouth. The doctor decides the dose and how long you take it, and may assess the benefit after a period of treatment. Swallow the tablet as your doctor or pharmacist advises. Do not change the dose or stop the medicine on your own. If you miss a dose or have questions about how to take it, ask your doctor or pharmacist.
Like all medicines, Angimet MR can cause side effects. Common ones include dizziness, headache, abdominal pain, diarrhoea, indigestion, nausea, vomiting, rash, itching, hives and weakness. Tell your doctor or pharmacist if you notice any of these or other unusual symptoms. Do not stop the medicine without advice. Ask your doctor or pharmacist about anything you are worried about.
Angimet MR is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris, and it is not a treatment for myocardial infarction. It should be avoided in people with Parkinson's disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment, or allergy to the active substance or any excipient. Avoid it during pregnancy and breast-feeding. Ask your doctor first if you have any of these conditions or are pregnant or breast-feeding.
The 35 mg strength means each Angimet MR tablet contains 35 mg of Trimetazidine Dihydrochloride. The tablet form means it is taken by mouth. The doctor decides the dose and course; do not change it yourself.
Angimet MR is an anti-anginal and anti-ischaemic medicine. It is used in adults as add-on therapy for the symptomatic treatment of stable angina pectoris when first-line antianginal therapies do not control symptoms or are not tolerated. The doctor decides if it is suitable.
Avoid it if you have Parkinson's disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment, or allergy to its ingredients. It should not be used during pregnancy or breast-feeding. Ask your doctor first if any of these apply to you.
The listed price is ৳ ৬.০০. Ask your pharmacist about availability and any other costs.
৳ ৫.৮৮ ৳ ৬.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Trimetazidine Dihydrochloride is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Trimetazidine Dihydrochloride is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Trimetazidine Dihydrochloride inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
No drug interaction so far has been reported. In particular, no interaction has been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparation.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Trimetazidine is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients. It is also is contraindicated in patients with Parkinson’s disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Trimetazidine is safe and well tolerated. The Common side effects associated with Trimetazidine are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and astheniaএই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Trimetazidine is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is also not a treatment for myocardial infarction.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Keep in a dry place away from light and heat. Keep out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।